- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Robin Henderson Says Mental Health Providers Can Be Their "Own Worst Enemy"
Some of the challenges with bringing as much focus to the mental well-being of patients as their physical conditions has to do with problems the healthcare industry created itself, according to Robin Henderson, PsyD.
Some of the challenges with bringing as much focus to the mental well-being of patients as their physical conditions has to do with problems the healthcare industry created itself, according to Robin Henderson, PsyD, director of behavioral health services and interim director of health integration at St. Charles Health System.
She explained that there is a self-imposed stigma that healthcare providers perpetrate, but that the healthcare industry also created a financing conundrum when it separated mental health funding from physical health spend.
“We need to bring all those things together so we stop being our own worst enemies,” Dr Henderson said.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Linvoseltamab Added as Preferred Agent in Newest MM Practice Guidelines
July 31st 2025On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory multiple myeloma (MM), and the most recent update to the National Comprehensive Cancer Network guidelines for MM has added the BCMA-targeted bispecific antibody as a preferred treatment option.
Read More
